Trials / Completed
CompletedNCT04672902
Treatment of Mirizzi Syndrome
Single-operator Cholangioscopy and Electrohydraulic Lithotripsy for the Treatment of Mirizzi Syndrome: A Case Series
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Tecnologico de Monterrey · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Mirizzi syndrome is an infrequent complication of long-standing cholelithiasis. Extrinsic compression of the common hepatic duct is usually caused by an impacted stone in Hartmann's pouch or cystic duct resulting in the development of cholecystobiliary fistula. This syndrome is classified based on the presence and severity of cholecystobiliary fistula. Mirizzi syndrome is challenging to diagnose preoperatively and may require complex biliary surgical procedures for resolution. Endoscopic treatment is a safe alternative with a high success rate. Single-operator cholangioscopy combined with lithotripsy has been shown to have a 90-100% success rate in the treatment of biliary stones. Herein, A single center experience treating Mirizzi syndrome with single-operator cholangioscopy guided electrohydraulic lithotripsy is presented. Difficult management of Mirizzi syndrome has led to research of new treatment options to minimize the risk of high rate complications. Single-operator cholangioscopy in combination with laser lithotripsy is an adequate and safe alternative for the treatment of this condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Single-operator cholangioscopy guided electrohydraulic lithotripsy | Single-operator cholangioscopy guided electrohydraulic lithotripsy has the advantage of providing direct visualization of the bile ducts, enabling a single physician to diagnose and perform the therapeutic intervention in a single procedure. |
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2020-12-17
- Last updated
- 2020-12-17
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04672902. Inclusion in this directory is not an endorsement.